Aqr Capital Management LLC Pmv Pharmaceuticals, Inc. Transaction History

Aqr Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.51 - $2.21 $5,952 - $8,711	3,942 Added 3.43%	118,917 $192,000
Q1 2024 May 15, 2024	SELL	$1.51 - $3.12 $64,431 - $133,130	-42,670 Reduced 27.07%	114,975 $195,000
Q4 2023 Feb 14, 2024	BUY	$1.23 - $6.6 $175,931 - $944,024	143,034 Added 978.95%	157,645 $488,000
Q3 2023 Nov 14, 2023	SELL	$6.01 - $8.93 $54,426 - $80,870	-9,056 Reduced 38.26%	14,611 $89,000
Q2 2023 Aug 14, 2023	BUY	$3.94 - $6.27 $93,247 - $148,392	23,667 New	23,667 $148,000

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $73.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.